Related Experiment Videos
Chloroquine-induced bilateral ptosis.
1Kwame Nkrumah University of Science and Technology School of Medical Sciences, Department of Medicine, Komfo Anokye Teaching Hospital, P.O. Box 1934, Kumasi, Ghana. gba@africaonline.com.gh
Transactions of the Royal Society of Tropical Medicine and Hygiene
|January 13, 2006
Summary
Bilateral ptosis, an eyelid condition, was observed following chloroquine treatment for malaria. This adverse event resolved after discontinuing the drug, highlighting the importance of monitoring drug safety.
Area of Science:
- Pharmacology
- Ophthalmology
- Tropical Medicine
Background:
- Chloroquine is a primary antimalarial drug used in sub-Saharan Africa.
- Understanding adverse drug reactions is crucial for patient safety.
Observation:
- A case of bilateral ptosis (drooping eyelids) was reported.
- The ptosis occurred within 24 hours of chloroquine administration.
- Symptoms resolved completely within 48 hours of drug cessation.
Findings:
- This is the first reported instance of chloroquine-induced bilateral ptosis.
- The temporal relationship suggests a causal link between chloroquine and ptosis.
Implications:
- Highlights a previously undocumented adverse effect of chloroquine.
- Emphasizes the need for vigilance regarding adverse events of widely used medications.
- May inform clinical practice and patient counseling for malaria treatment.